Clinical Trial Update: A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of different doses of NNC0662-0419 in overweight and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• NNC0662-0419

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING